Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model

Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

(2014) Emma H. Allott et al.   BJU INTERNATIONAL

Mounting Evidence for Prediagnostic Use of Statins in Reducing Risk of Lethal Prostate Cancer

(2013) Lorelei A. Mucci et al.   JOURNAL OF CLINICAL ONCOLOGY

Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression

(2013) J C Lloyd et al.   PROSTATE CANCER AND PROSTATIC DISEASES

27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology

(2013) E. R. Nelson et al.   SCIENCE

Impact of Circulating Cholesterol Levels on Growth and Intratumoral Androgen Concentration of Prostate Tumors

(2012) Elahe A. Mostaghel et al.   PLoS One

A meta-analysis of fat intake, reproduction, and breast cancer risk: An evolutionary perspective

(2011) Laurah B. Turner   AMERICAN JOURNAL OF HUMAN BIOLOGY

Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?

(2011) Vasilios G. Athyros et al.   ANNALS OF MEDICINE

Serum total and HDL cholesterol and risk of prostate cancer

(2011) Alison M. Mondul et al.   CANCER CAUSES & CONTROL

Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study

(2011) Mieke Van Hemelrijck et al.   CANCER CAUSES & CONTROL

Statins and Prostate Cancer Diagnosis and Grade in a Veterans Population

(2011) W. R. Farwell et al.   JNCI-Journal of the National Cancer Institute

Dietary intervention induces flow of changes within biomarkers of lipids, inflammation, liver enzymes, and glycemic control

(2011) Rachel Golan et al.   NUTRITION

Blood lipid levels and prostate cancer risk; a cohort study

(2011) D E G Kok et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Low-Carbohydrate Diets and Prostate Cancer: How Low Is "Low Enough"?

(2010) E. M. Masko et al.   Cancer Prevention Research

Atorvastatin and Celecoxib in Combination Inhibits the Progression of Androgen-Dependent LNCaP Xenograft Prostate Tumors to Androgen Independence

(2010) X. Zheng et al.   Cancer Prevention Research

Increase of oxidant-related triglycerides and phosphatidylcholines in serum and small intestinal mucosa during development of intestinal polyp formation in Min mice

(2010) Kazutaka Ikeda et al.   CANCER SCIENCE

Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

(2010) Eek Joong Park et al.   CELL

Pancreatic Cancer: Epidemiology and Risk Factors

(2010) Guenter J. Krejs   DIGESTIVE DISEASES

Anticancer Efficacy of Simvastatin on Prostate Cancer Cells and Tumor Xenografts Is Associated with Inhibition of Akt and Reduced Prostate-Specific Antigen Expression

(2010) S. T. Kochuparambil et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Effect of intermittent fasting on prostate cancer tumor growth in a mouse model

(2010) J A Thomas et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Ezetimibe Is an Inhibitor of Tumor Angiogenesis

(2009) Keith R. Solomon et al.   AMERICAN JOURNAL OF PATHOLOGY

Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers

(2009) Isabel Gonçalves et al.   AUTOIMMUNITY

Simvastatin protects against cholestasis-induced liver injury

(2009) S Dold et al.   BRITISH JOURNAL OF PHARMACOLOGY

Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia

(2009) Fawaz Almutairi et al.   LIVER TRANSPLANTATION

The Homeodomain Protein HOXB13 Regulates the Cellular Response to Androgens

(2009) John D. Norris et al.   MOLECULAR CELL

Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial Cells at therapeutic concentrations

(2009) Teemu J. Murtola et al.   PROSTATE

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes

(2008) Christopher P. Cannon et al.   AMERICAN HEART JOURNAL

The Influence of Statin Medications on Prostate-specific Antigen Levels

(2008) Robert J. Hamilton et al.   JNCI-Journal of the National Cancer Institute

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

(2008) Anne B. Rossebø et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analyses of Cancer Data from Three Ezetimibe Trials

(2008) Richard Peto et al.   NEW ENGLAND JOURNAL OF MEDICINE